Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update
Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, will announce its unaudited interim results for the six months ended 30 June
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as
The Golden Goose
Fintech firm Glantus Holdings PLC (AIM: GLAN), a UK small-cap, has succumbed to the ongoing trend of take-private offers affecting the junior market.
Salistick™, the first ever saliva pregnancy test, to be launched in Tesco
Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study
Superdrug to sell Salistick™, the first ever saliva pregnancy test, initially in 400 stores and online Salistick™ also to launch on the Abingdon Simply Test website
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, notes the recent market speculation regarding possible fundraising.
Avacta Annual General Meeting and Shareholder Event Detailed Agenda
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake